It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2002.
2002 | New Delhi, Delhi, India | ActiveProbest Pharma Private Limited, a active private limited company, was established on 28 February 2002 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U24239DL2002PTC114413. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Surinder Khurana (Director), Manpreet Singh Khurana (Director), Narendra Pal Singh (Director). Past directors included Surinder Khurana, Ashutosh Arora, Pradeep Aswal. It holds ₹0.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1537/28 Ist Floor , Naiwala Karol Bagh, New Delhi, Delhi, 110005.
U24239DL2002PTC114413
114413
28 February 2002
₹0.20 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Probest Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surinder Khurana | Director | 13 Sep 2024 | Current |
| Manpreet Singh Khurana | Director | 28 Feb 2002 | Current |
| Narendra Pal Singh | Director | 22 Feb 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 22 Feb 2008 | Past |
| Pramod Abcsdd | Managing Director | 22 Feb 2008 | Past |
| Pramod Abcsdd | Director | 22 Feb 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Probest Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.13% increase. The company also saw a substantial fall in profitability, with a 69.22% decrease in profit. The company's net worth moved up by a moderate rise of 3.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Probest Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2008 | Punjab & Sind Bank | ₹0.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Probest Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Probest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Probest Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Probest Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Surinder Khurana was appointed as a Director was appointed as a Director on 13 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Probest Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Punjab & Sind Bank of Rs. 0.70 M registered on 07 Aug 2008 with Charge ID 10118797 was modified on 25 Feb 2013. was completed.
The activity A charge with Punjab & Sind Bank amounted to Rs. 0.70 M with Charge ID 10118797 was registered on 07 Aug 2008. was completed.
Narendra Pal Singh was appointed as a Director was appointed as a Director on 22 Feb 2008 & has been associated with this company since 17 years 9 months . was recorded as a recent event.
The CIN of Probest Pharma Private Limited is U24239DL2002PTC114413.
Probest Pharma Private Limited is headquartered at 1537/28 Ist Floor , Naiwala Karol Bagh, New Delhi, Delhi, 110005.
Probest Pharma Private Limited was incorporated on 28 February 2002.
The current directors of Probest Pharma Private Limited are
The primary industry of Probest Pharma Private Limited is Manufacturing.
Probest Pharma Private Limited is unlisted.
The authorized capital of Probest Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.
The compliance status of Probest Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX